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Abstract 
Duchenne muscular dystrophy (DMD) is an inherited, lethal disorder characterised by progressive muscle degeneration and 
associated bone abnormalities. We have previously demonstrated that P2RX7 purinergic receptors contribute to the 
pathogenesis of DMD, and found that P2RX7 ablation alleviated the severity of the disease. In this work we have used a 
dystrophic mdx mouse crossed with the global P2RX7 receptor to generate a knockout mouse (mdx/P2X7
-/-
), and compared its 
morphometric, mechanical and tissue properties against those of mdx, as well as the wild type (WT) and the P2RX7 knockout 
(P2X7
-/-
).  Micro-computed tomography (µCT), three-point bending testing, scanning electron microscopy (SEM) and nano-
indentation were utilised in the study. The bones were analysed at approximately 4 weeks of age to examine the impact of 
P2RX7 ablation on the bone properties during the acute disease phase, before muscle wasting is fully developed. The results 
show that P2RX7 purinoceptor ablation has produced improvement or significant improvement in some of the morphological, 
the mechanical and the tissue properties of the dystrophic bones examined. Specifically, although the ablation produced 
smaller bones with significantly lower total cross-section area (Tt.Ar) and Second Moment of Area (SMA), significantly higher 
cortical bone area (Ct.Ar), cortical bone area ratio (Ct.Ar/Tt.Ar) and trabecular bone volume fraction (BV/TV) are found in the 
mdx/P2X7-/- mice than in any other types. Further, the mdx/P2X7
-/-
 bones have relatively higher average flexural strength, 
work-to-fracture and significantly higher strain to failure compared with those of mdx, suggesting greater resistance to fracture. 
Indentation modulus, elasticity and creep are also significantly improved in the knockout cortical bones over those of mdx. 
These findings seem to suggest that specific pharmacological blockade of P2RX7 may improve dystrophic bones, with a 
potential for therapeutic application in the treatment of the disease.  
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INTRODUCTION 
Duchenne muscular dystrophy (DMD) is the most 
common type of muscular dystrophy causing 
progressive muscle degeneration leading to severe 
disability and death of young men. DMD is also 
associated with cognitive impairment. Both patients 
(Rufo et al., 2011) and mdx (DMD model) mice  
(Nakagaki et al., 2011) were found to have lower bone 
mass, which is strongly associated with the degree of 
motor function and muscle strength. 
The ability of bone to adapt to mechanical loads is 
usually linked to muscle activity, and bone loss in 
muscle paralysis is indicative of the importance of 
mechanical stimulation for bone regulation. In the late 
stages of DMD progression, the impact of muscle loss 
on the dystrophic bone structure is evident. However, 
early bone abnormalities found prior to substantial 
muscle loss indicate that there may be other factors 
inherent to DMD, which also contribute to the loss of 
bone mass (Anderson et al., 1993; Bianchi and 
Morandi, 2008; Nakagaki and Camilli, 2012). Studies by 
Anderson et al. (1993), Rufo et al. (2011) and Novotny 
et al. (2011) showed up to 50% loss in strength and 
stiffness in mdx mouse model of DMD compared to 
those of the control, resulting in the development of 
micro-damage (Saito and Marumo, 2010) and bone 
fracture (Bianchi and Morandi, 2008). 
Several scenarios have been envisaged on the 
mechanisms behind the DMD bone abnormality (Abou-
Khalil et al., 2013; Bianchi et al., 2003; Rufo et al., 
2011). DMD causes absence of dystrophin, which 
disrupts structural scaffolds involving dystrophin-
associated proteins and loss of anchoring for specific 
signalling proteins (Blake et al., 2002). Therefore, the 
absence of dystrophin could be directly responsible for 
bone structure alterations. However, there is no data 
on dystrophin being expressed in osteoblasts or 
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osteoclasts. On the other hand, dystrophic muscle 
degeneration is associated with chronic sterile 
inflammation. Abou-Khalil et al. (2013) demonstrated 
that chronic inflammation contributes to dystrophic 
bone damage. In DMD patients, prolonged 
corticosteroid treatment can further exacerbate this 
abnormality (Bianchi et al., 2003; Söderpalm et al., 
2007).   
DMD gene mutations are associated with P2RX7 
purinoceptor up-regulation, which leads to the death 
of both human DMD (Ferrari et al., 1994) and mdx cells 
(Yeung et al., 2006; Young et al., 2012). P2RX7 
activation in mdx muscles triggers a specific 
mechanism of autophagic cell death (Young et al., 
2015). Recent work showed that this receptor is a good 
target for pharmacological treatment of DMD, as its 
genetic ablation (knockout) reduced both muscle loss 
and inflammation (Sinadinos et al., 2015). P2RX7 is 
expressed in both osteoblasts and osteoclasts, but it 
appears to have different roles in bone physiology and 
in disease states. If P2RX7 is abnormally active in 
dystrophic bones, its absence might improve the bone 
properties.  On the other hand, activation of P2RX7 
receptor has been linked primarily to osteoclast 
functions (Agrawal and Gartland, 2015; Gartland, 2012; 
Ke et al., 2003), hence its ablation could have a 
negative impact on the bone.  We hypothesize that 
P2RX7 ablation would not exacerbate the dystrophic 
bone phenotype.  
To test this hypothesis, we have used a previously 
established double mutant (mdx/P2X7-/-, Sinadinos et 
al., 2015), examined the morphometric, mechanical 
and tissue properties of long bones of mdx/P2X7
-/- 
mice 
against
 
those of mdx as well as wild type (WT) and 
P2RX7 knockout (P2X7
-/-
) mice,
 
using µCT imaging, 
three-point bending testing and nanoindentation.  
 
MATERIALS AND METHODS 
Animal models 
The mdx mouse is considered the most appropriate 
pre-clinical model to test treatment efficacy for DMD 
(http://www.treat-nmd.eu/research/preclinical/dmd-
sops/). All animal experiments were performed in 
accordance with the approvals of the Institutional 
Ethical Review Board and the Home Office UK 
(70/7479).  
The mdx/P2X7
-/-
 were generated by crossing P2RX7 
receptor knockout male mice (Solle et al., 2001) with 
mdx C57Bl/10ScSn-Dmdmdx/J female mice (Harlan 
Lab, UK), and genotypes were confirmed by genomic 
DNA PCR (Sinadinos et al., 2015). Animals were 
maintained in a 12 hours light/dark cycle and fed 
normal diet and water ad libitum. The mouse bones 
were analysed at approximately 4 weeks of age, when 
the disease is fully manifested but the muscle loss and 
its effects on bone properties are thought not yet 
significant.  A total of 24 male mouse bones were used 
in the study. These included wild-type (C57BL10, n=6), 
dystrophic (mdx, n=6) (Bulfield et al., 1984), P2X7
-/-
 
(n=6) (Solle et al., 2001) and mdx/P2X7
-/-
 (n=6) (Young 
et al., 2015), as summarised in Table 1.  
Sample Preparation 
Tibias were dissected clean of muscles under a stereo-
microscope, and placed in 10% buffered formalin 
overnight prior to saline storage at 4°C.  The tibias 
were kept in the saline solution until they were ready 
for scanning and mechanical testing. Left tibias for 
each of the genotypes were used for µCT scanning 
after about 2 weeks in the saline solution, followed by 
three-point bending testing, SEM examination and 
nanoindentation in up to 50 weeks.  
Micro-computed tomography (µCT)  
The tibias were scanned using µCT X-Ray Inspection 
System (X-Tek Systems Ltd). The sample was fixed in a 
specimen holder and positioned vertically to allow a 
full 360° rotation. The holder was placed as close as 
possible to the detector to achieve high resolution. The 
x-ray settings for imaging were: V = 50-55kVp, I = 95-
110μA and rotational step = 0.19°/360°. The voxel size 
was about 6-8μm
3
.  
A full data acquisition took approximately 90 minutes 
and the dataset was stored in VGI format prior to 
visualisation using VG Studio Max 2.0 (Volume 
Graphics, Germany). Further, CTPRO (Metris X-Tek, UK) 
was used to reduce noise and beam hardening 
artefacts. ImageJ (NIH, US) was used for image 
processing; whilst BoneJ (Doube et al., 2010)  was used 
for image analysis and the determination of key bone 
parameters (Bouxsein et al., 2010). The determination 
of the threshold for bone segmentation was based on 
visual inspection and automatic thresholding (IsoData 
algorithm) (Bouxsein et al., 2010; Stock, 2009). The 
algorithm divides the image into object and 
background by taking an initial threshold, then the 
averages of the pixels at or below the threshold and 
pixels above are computed (Ridler and Calvard, 1978). 
The average of these two values was then computed, 
and the process was repeated until the threshold is 
larger than the composite average. The analyses were 
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carried out in the regions of interest (ROI), as 
illustrated in Figure 1. A total of 100 contiguous µCT 
slices were taken 0.50 mm below the growth plate in 
the metaphyseal region of the proximal tibia, from 
which cortical and cancellous bones were separated 
manually to obtain the parameters for the trabecular 
bone; whilst 54 contiguous µCT slices were assessed 
4.32 mm from the growth plate in the mid-tibia to 
characterise the cortical bone.  
Three-point bending testing 
The biomechanical properties of bones from each 
genotype were determined using a three-point 
bending arrangement (Vashishth, 2008). The bending 
jig has a V-shaped support to secure the distal and the 
proximal ends of the tibia during testing. The tibia was 
positioned horizontally with the anterior side upwards, 
and the load was applied downwards in the centre of 
the mid-tibia. The distance between the supports was 
7 mm (Silva et al., 2004). The bones were loaded at a 
constant displacement rate of 0.155 mm/s until failure 
using a BOSE Testing Machine (ElectroForce® 3200). 
The load-displacement curves were obtained and used 
for the calculation of the structural and material 
properties, including peak load; flexural modulus, 
determined by the slope of the linear part of the load-
displacement curve, and work-to-fracture, defined by 
the area under the load-displacement curve.  The 
cross-sectional second moment of area (SMA) in the 
loading direction (anterior-posterior) was determined 
using the algorithm in BoneJ, where the two 
orthogonal axes, anterior-posterior and medial-lateral, 
intersect at the centroid. An average value of SMA was 
obtained from the values calculated from 20 slices 
taken in an area close to the load application. The 
stress and strain were obtained using Equations (1) and 
(2) (Jepsen et al., 2015; Turner, 2002):  
 
    (1) 
    (2) 
where is the stress, F is the load, L is the length of 
the span, c is the distance from the centroid of the 
cross-section along the anterior-posterior axis to the 
edge of the cross-section in tension, I is the SMA,  is 
the strain, and d is the displacement. The flexural 
strength and strain at failure were obtained from the 
stress-strain curves. 
Scanning Electron Microscopy (SEM) 
Following the three-point bending tests, the fracture 
surfaces of the failed distal tibias of each genotype 
were investigated using SEM to identify the possible 
mechanisms responsible for fracture. The tibias were 
coated with gold-palladium (Bozzola and Russel, 1999) 
and stored in a dust-free desiccator before scanning. 
The sample was placed horizontally in the SEM 
chamber (JSM-6060LV, JEOL, Japan) and the analyses 
were carried out at 15kV, with resolutions between 10 
and 500 µm to enable the analysis at both macro and 
micro levels.  
Nanoindentation 
Nanoindentation was performed using a CSM-Nano 
Hardness Tester System (CSM Instruments SA; 
Switzerland; Indentation v.3.83), with a Berkovich-
based pyramid diamond indenter, following the 
standard ISO 4577-1:2015. The bone preparation 
followed the procedures described in (Finnilä et al., 
2010; Herlin et al., 2013; Zioupos and Rogers, 2006). 
Briefly the left tibias were cleaned, ultrasonicated and 
dried in a desiccator before being embedded in a low 
viscosity Kleer-Set resin (MetPrep, Conventry, UK). The 
specimens were then ground using silicon carbide 
papers and finally polished using 0.05 micron -
alumina slurry (Zioupos and Rogers, 2006). For 
trabecular bones, the individual trabeculae were 
supported by injecting low viscosity superglue into the 
pores in the trabecular network unfilled by the Kleer-
set resin. The average values of 8 indentations in 
cortical bone samples and 3 to 5 indentations in 
trabecular bone samples were taken in advanced 
(standard) and dynamic loading protocols. The 
indentation targets were carefully selected in the 
centre of the intended bone tissue using an optical 
microscope (Zhang et al., 2015).  
For the advanced protocol, a trapezoidal loading 
waveform was applied with a loading/unloading rate of 
20mN/min, plus a 30s hold at the maximum load 
10mN. In the dynamic protocol, a sinusoidal waveform 
was used with a frequency of 1.0Hz and an amplitude 
of 1.0mN. The hardness and indentation modulus were 
measured following Oliver and Pharr (1992). The elastic 
modulus and Poisson’s ratio of the diamond indenting 
were 1142 GPa and 0.07, respectively. The viscoelastic 
behaviour of the bones was analysed using the 
dynamic protocol (Finnilä et al., 2010), where the 
values of storage and loss modulus were calculated 
from the loading curve using Dynamic Mechanical 
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Analysis (CSM V3.75), using stabalised data after a 
penetration depth over 100nm.    
Statistical Analysis 
The mean and the standard deviation were reported 
for all the morphometric, mechanical and 
nanoindentation parameters. Comparisons were made 
between mdx and each of the other three genotypes, 
Wild-type (WT), P2X7
-/-
 and mdx/P2X7
-/-
. The non-
parametric Kruskal-Wallis test was used to test the 
difference between each pair (i.e. WT vs mdx; P2X7
-/-
 
vs mdx and mdx/P2X7
-/- 
vs mdx) and significant 
differences were indicated when p-value<0.05. All test 
assumptions were verified and analyses were carried 
out using SPSS (PASW version 18.0).   
 
RESULTS  
Morphometric analysis  
The morphometric properties of the four genotypes in 
both cortical (midtibia) and trabecular (proximal tibial 
metaphyseal) bones are presented in Table 2, and 
comparisons were made between the results of mdx 
and each of the other three genotypes. In cortical 
bones, the mdx/P2X7
-/- 
mice have significantly lower 
total cross-sectional area (Tt.Ar) than those of all the 
other three types (WT (p=0.004); P2X7
-/-
 (p=0.004) and 
mdx (p=0.004), consistently, the SMA in mdx/P2X7
-/- 
mice is significantly lower than all the other three 
types, suggesting smaller bones in the double knockout 
mice.  By contrast, however, the cortical bone area 
(Ct.Ar) and cortical area fraction (Ct.Ar/Tt.Ar) of 
mdx/P2X7
-/- 
mice are significantly higher than those of 
mdx. For trabecular bones, significantly higher BV/TV 
of mdx/P2X7
-/- 
mice is also found compared with that 
of mdx, although the other parameters, including 
trabecular thickness, spacing and connectivity, are not 
statistically different between those of mdx/P2X7
-/- 
and 
mdx mice.  These results clearly show a positive impact 
of P2RX7 ablation on both cortical bone and trabecular 
bone. 
Mechanical Properties 
Figure 2 shows the individual stress-strain curves for 
the four genotypes, from which stiffness, maximum 
load, work-to-fracture, strain at failure were 
determined, whilst the flexural strength was calculated 
using Eq. (1).  Post-yield stress-strain curves clearly 
show greater strain to failure in mdx/P2X7
-/-
 bones 
than most of the other types including those of mdx. 
Table 3 shows the mean and the standard deviation of 
the mechanical properties for the four genotypes, and 
statistically significant differences are indicated. 
Significantly lower stiffness (by 53%, p=0.010) is found 
in mdx/P2X7
-/-
 compared to that of mdx. Although the 
average maximum load achieved in mdx/P2X7
-/-
 bones 
is relatively lower than that of mdx bones (2.430.45 vs 
3.100.90), the average flexural strength in mdx/P2X7
-
/-
 bones is relatively higher than that of mdx bones 
(62.9717.39 vs 49.6519.09.  Figure 3 shows the 
measured mean, the standard deviation and the 
spread of the mechanical properties, including the 
medians, the 25 and 75 percentiles and the outliers, in 
boxplots for the four genotypes. It seems that the 
measured low maximum load and stiffness in the 
mdx/P2X7
-/-
 bones have not translated into low 
material properties. In fact relatively higher, although 
not statistically significant, average flexural strength 
and work-to-fracture are found in the mdx/P2X7
-/-
 mice 
compared with those of mdx (Table 2). Significantly 
higher strain at failure is obtained in the mdx/P2X7
-/-
 
mice compared with those of both WT (by 60%, 
p=0.008) and mdx mice (by 79%, p=0.008), indicating 
greater ductility and resistance to fracture.  
The fracture surfaces of the typical samples are shown 
in Figure 4.  More brittle type of fracture found in mdx 
mice stands in contrast to the more ductile fracture 
found in the mdx/P2X7
-/-
 bones as well as in the WT. 
The paths of the fracture are indicated in Figure 4(A), 
where instantaneous brittle fracture along the weak 
planes appears to be found in mdx bone, as opposed to 
the fibrous fracture surfaces found in WT and the 
knock-out bones, latter indicating gradual separation 
of the bones as a result of competition between 
cracking and fibre bridging. Figure 4(B) shows the cross 
sections of the failed samples, where the posterior 
surface was in tension and anterior surface was in 
compression. High magnification images at selected 
resolutions are shown in Figure 4(C) to reveal the 
micro-fracture mechanisms in the posterior area, 
where maximum tension led to the initiation of cracks. 
It seems that rougher fracture surfaces characterise 
the samples of WT, P2X7
-/- 
and mdx/P2X7
-/-
, as opposed 
to relatively smoother fracture surfaces in mdx bones. 
This observation seems to be consistent with the 
results presented in Table 3 and Figure 3, where higher 
values of strain at failure and work-to-fracture are 
obtained from the mdx/P2X7
-/- 
bones compared with 
those from the mdx bones.  
Nanoindentation 
Table 4 shows the mean and the standard deviation of 
nano-indentation parameters from the advanced 
(Table 4a) and the dynamic (Table 4b) protocols. For 
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cortical bones, statistically significant differences in the 
hardness, indentation modulus, elasticity and creep are 
observed between mdx and WT; and between 
mdx/P2X7
-/-
 and mdx mice. Significantly lower hardness 
and elasticity (the elastic part of the indentation work), 
but higher creep and modulus are found in the mdx 
mice than in the WT mice; whilst lower modulus and 
creep but higher hardness and elasticity are found in 
the mdx/P2X7
-/-
 than those in mdx mice, hence the 
double-mutant mice show properties closer to those of 
WT than those of mdx. For trabecular bones, however, 
there seem no statistically significant differences 
between the properties of WT and mdx; and those of 
mdx/P2X7
-/- 
and mdx.  Similar values in elasticity and 
creep are obtained across the genotypes, although 
significant differences are found in hardness and 
modulus between the knockout and WT bones.   
For dynamic indentation, the elasticity in the cortical 
bones of mdx mice is significantly lower than that of 
WT mice (p=0.007), whilst higher storage modulus is 
found in mdx trabecular bones than that in WT mice 
(p=0.001).  Statistically significant difference is found in 
loss modulus (p=0.025) between the mdx/P2X7
-/- 
and 
the mdx in the cortical bone.  Otherwise the values of 
storage modulus (trabecular bone), loss modulus 
(trabecular bone) and elasticity (cortical bone) in the 
mdx/P2X7
-/- 
bones appear to be closer to those of WT 
mice. 
A linear regression analysis shows that creep decreases 
with the increase in elasticity for all WT, mdx and 
mdx/P2X7
-/-
 bones (p<0.01), and the negative 
correlations between creep and elasticity are shown in 
Figure 5 for cortical bones.  
 
DISCUSSION 
In this work, the effects of P2RX7 ablation on bone 
morphological, mechanical and tissue parameters have 
been examined.  As revealed from the Kruskal-Wallis 
analysis, the ablation led to smaller bones, with 
significantly lower cross-sectional area (Tt.Ar) and SMA 
in mdx/P2X7-/- mice than other types.  However, 
significantly more bone per area/per volume is found 
in mdx/P2X7-/- mice than all other types, as indicated 
by the significantly higher bone area (Ct.Ar) and bone 
area ratio (Ct.Ar/Tt.Ar) for cortical bone, and 
significantly higher bone volume fraction (BV/TV) for 
trabecular bone. The ablation does not seem to affect 
the architecture of the trabecular bone though, as 
indicated by the similar values of trabecular thickness 
(Tb.Th), trabecular spacing (Tb.Sp) and connectivity 
(Conn.D), as shown in Table 2.  Compared with mdx 
bones, mdx/P2X7-/- mice have significantly higher 
cortical bone area (0.1720.01 vs 0.1300.018, mm
2
), 
significantly higher  cortical bone area ratio 
(0.4110.031 vs 0.3600.015, %) and significantly 
higher trabecular bone volume fraction (0.180.036 vs 
0.1250.027, % Table 2), higher average flexural 
strength (62.9717.39 vs 49.6519.09, MPa), work to 
fracture (4.592.06 vs 3.311.36, Nmm) and 
significantly higher strain at fracture (0.390.12 vs 
0.140.04)(Table 3).  In terms of tissue properties, 
hardness and elasticity are significantly higher whilst 
indentation modulus and creep significantly lower than 
those of mdx.  Thus overall the ablation seems to have 
improved the bone properties.  Preliminary work (n=2) 
has also been carried out to measure the bone mass 
using Thermogravimetry Analysis (TGA), where both 
mineral and organic contents are slightly higher in 
mdx/P2X7
-/-
 bones than those in mdx bones 
(10.821.17 vs 9.530.43; 25.791.52 vs 21.060.24), 
which might have contributed to the higher flexural 
strength and strain to failure.  
The mechanisms that led to the changes in the bones 
due to the loss of P2RX7 may be complex and require 
further studies, which are beyond the scope of this 
paper. It is known, however, that P2RX7 is expressed in 
both osteoblasts and osteoclasts, but it appears to 
have significantly different roles in bone physiology 
and in disease states.  It is unclear if P2RX7 knockout 
affects bone formation or bone resorption or, perhaps, 
both (Agrawal and Gartland, 2015; Ke et al., 2003). In 
this work, we have examined the influence of P2RX7 
inhibition, which is known to have therapeutic effects 
on skeletal muscles, on the morphological and the 
mechanical behaviour of the bones. Given that the 
bone abnormalities in mdx mice have been linked to 
chronic inflammation (Abou-Khalil et al., 2014), the 
reduced inflammation found in mdx/P2X7-/- muscles 
(Sinadinos et al., 2015) may be responsible for the 
reduced bone loss in these mice.  Importantly, the 
significantly higher bone volume in both cortical and 
trabecular mdx/P2X7-/- bones would seem to suggest 
that the overall effect of the ablation is bone formation 
for the models we studied. The longer-term effects of 
P2RX7 receptor ablation have also been tested, and 
there is a significant improvement in bones of 6 
months old mdx/P2RX7-/- mice (Sinadinos et al., 2015).  
However, at this stage it is difficult to ascertain 
whether the mechanism is not secondary to the 
improvements in muscle morphology observed in the 
later phases of mdx pathology. 
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Quantitative assessments of strength and toughness of 
small animal bones may be carried out using a number 
of approaches (Jepsen et al., 2015; Ritchie et al., 2008). 
For toughness characterisation, work-to-fracture has 
the advantage of measuring both strength and 
toughness using the same un-notched specimen at the 
same time, although the measured properties are 
usually size-dependent. Fracture toughness 
measurements require a pre-crack, which is considered 
best suited for characterisation of the inherent 
resistance of a material to fracture (Ritchie et al., 
2008). In this work, we have adopted the former due 
to the similar sizes of the samples across the 
phenotypes, and for the convenience and the lack of 
ambiguity of the measured mechanical properties in 
strength, stiffness and work-to-fracture. Our approach 
follows the guidelines for the assessment of 
mechanical properties of mouse bones (Jepsen et al., 
2015).  A variety of toughening mechanisms (Li et al., 
2013) might be at work giving rise to the ductile 
behaviour observed particularly in mdx/P2X7
-/-
 bones. 
Pulling out of collagen fibrils can be observed 
particularly in P2X7
-/-
 and mdx/P2X7
-/-
, where twisted 
collagen fibrils are also evident. This may interrupt the 
propagation of cracks resulting in higher resistance to 
fracture and greater strain to failure.  
In this work the specimens were fixed in phosphate 
buffered formal saline (PBFS) solution for long term 
storage with limited tissue shrinkage for CT scanning 
and mechanical testing.  Although fixing bone samples 
in formalin is one of the common fixation methods for 
microscopic studies, there have been reports on the 
variation of the strength measured in embalmed 
samples, possibly due to increase in collagen cross-
linking.  Nevertheless, as the same fixation method was 
used for all the samples examined here, the relative 
values of mechanical properties obtained should be 
useful for comparison purposes. The nanoindentation 
was carried out in dry conditions, a common practice 
adopted for easy comparison with published work and 
for reducing some of the influential factors such as 
vibration noise and hydration state of the bones.  
Although the modulus measured in wet is known to be 
about 10-20% lower than that in dry, this was not 
considered an issue for group comparison purposes. 
 
CONCLUDING REMARKS  
P2RX7 ablation has produced some significant 
improvements in the morphometric, mechanical and 
tissue properties of dystrophic long bones. Our results 
show that the curative impact of this receptor ablation 
on the bone pathology is notable from the very early 
phase of disease. This effect seems long-lasting as we 
have found improved morphometric bone parameters 
in 6 month old mdx/P2X7
-/-
 mice (Sinadinos et al., 
2015), although the life-long effects of P2RX7 ablation 
on such properties remain to be studied.  Nevertheless 
the current results seem to be encouraging in that 
selective P2RX7 antagonists might be of promise as a 
candidate for therapeutic trials for the treatment of 
this lethal disease. 
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Table 1. The types of mouse used in this study. 
 
 
 
 
 
Table 2. Morphometric properties of the bones of the genotypes studied. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a,b,c and bold text indicate p<0.05 (Kruskal-Wallis) 
astatistically significant difference (<0.05) with WT. 
bstatistically significant difference (<0.05) with mdx. 
cstatistically significant difference (<0.05) with P2RX7-/-. 
Genotype Genetic background Age  Gender n 
WT C57BL10, wild-type mice. 28 days Male 6 
mdx DMD gene mutant 
(dystrophic) mice on the 
C57BL10 background 
(Bulfield et al., 1984). 
29 days and 31 
days 
Male 6 
P2RX7-/- P2RX7 receptor knockout 
mice (Solle et al., 2001). 
29 days and 31 
days 
Male 6 
mdx/P2RX7-/- mdx and P2RX7 receptor 
knockout (double mutant) 
mice (Young et al., 2015). 
28 days Male 6 
Properties WT mdx P2RX7-/- mdx/P2RX7-/- 
     
Cortical     
(Midtibia)     
Tt.Ar (mm2) 1.344±0.263 1.216±0.114 1.089±0.139 0.722±0.123 a,b,c 
Ct.Ar (mm2) 0.160±0.017 0.130±0.018a 0.161±0.030b 0.172±0.01b 
Ct.Ar/Tt.Ar (%) 0.405±0.038 0.360±0.015 0.419±0.026 0.411±0.031a,b,c 
Cr.Th (mm) 0.150±0.017 0.123±0.010a 0.137±0.014 0.115±0.009a,c 
Second Moment of 
Area (SMA) (mm4) 
0.11±0.03 0.09±0.03 0.08±0.03 0.04±0.01a,b,c 
    
Trabecular    
(Proximal tibial metaphyseal)    
BV/TV (%) 0.193±0.066 0.125±0.027a 0.265±0.125b 0.180±0.036b 
Trab.Th (mm) 0.052±0.004 0.042±0.004 a 0.053±0.015 0.043±0.005a 
Trab.Sp (mm) 0.258±0.055 0.242±0.040 0.190±0.028a,b 0.223±0.059 
Conn.D (1/mm3) 113.92±73.05 162.41±90.16 140.79±76.86 125.98±93.19 
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Table 3. The mechanical properties of the bones of the genotypes. 
a,b,c and bold text indicate p<0.05 (Kruskal-Wallis) 
astatistically significant difference (<0.05) with WT. 
b statistically significant difference (<0.05) with mdx. 
c statistically significant difference (<0.05) with P2RX7-/-. 
 
 
 
 
Table 4a. Nanoindentation results produced by using the ‘advanced’ loading protocol for the tissue 
properties of the mouse bones.  
a,b,c and bold text indicate p<0.05 (Kruskal-Wallis) 
astatistically significant difference (<0.05) with WT. 
bstatistically significant difference (<0.05) with mdx. 
cstatistically significant difference (<0.05) with P2RX7-/-. 
 
 
 
 
Bone properties WT mdx P2RX7-/- mdx/P2RX7-/- 
Maximum load (N) 4.99±0.89 3.10±0.90a  4.32±1.63 2.43±0.45a,c 
Stiffness (N/mm) 12.16±2.12 7.19±2.58a 8.64±2.73a 3.38±1.51a,b,c 
Work-to-fracture (N·mm) 4.01±1.00 3.31±1.36 5.79±2.02 4.59±2.06 
Flexural Strength (MPa) 60.49±9.74 49.65±19.09  73.36±48.27 62.97±17.39 
Strain at Failure 0.15±0.02c 0.14±0.04 0.37±0.15b 0.39±0.12a,b 
Material properties WT mdx P2RX7-/- mdx/P2RX7-/- 
     
Cortical Advanced     
Hardness (MPa) 643.65±66.62 616.27±57.42a 628.36±57.36 637.89±49.58b 
Ind. Modulus (GPa) 17.28±1.91 18.31±1.52a 16.87±1.22b 17.44±1.28b,c 
Elasticity (%) 22.88±2.25 20.34±2.12a 22.76±2.75b 22.63±2.59b 
Creep (%) 5.89±1.05 6.81±1.15a 6.02±1.23b 5.92±0.91b 
     
Trabecular Advanced     
Hardness (MPa) 437.14±104.63 475.65±97.37 523.46±98.60a 505.79±102.47a 
Ind. Modulus (GPa) 10.97±1.87 11.77±2.18 12.56±1.98a 12.48±2.07a 
Elasticity (%) 24.58±2.86 24.40±3.56 24.93±4.80 24.40±3.60 
Creep (%) 6.53±1.08 6.77±1.90 6.18±2.17 6.55±1.58 
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Table 4b. Nanoindentation results produced by using the ‘dynamic’ loading protocol for the tissue 
properties of the mouse bones.  
a,b,c and bold text indicate p<0.05 (Kruskal-Wallis) 
astatistically significant difference (<0.05) with WT. 
bstatistically significant difference (<0.05) with mdx. 
cstatistically significant difference (<0.05) with P2RX7-/-. 
  
 
  
 
 
 
 
 
 
 
Material properties WT mdx P2RX7-/- mdx/P2RX7-/- 
     
Cortical Dynamic     
Phase Difference (∂) 3.50±0.61 3.72±1.01 4.14±1.04 4.13±0.91a 
Storage Modulus (GPa) 20.63±2.29 20.13±2.05 19.33±2.19 21.31±1.86c 
Loss Modulus (GPa ) 1.28±0.27 1.32±0.32 1.43±0.44 1.56±0.33a,b 
Elasticity (%) 21.36±2.04 19.36±1.78a 20.85±2.08b 20.56±2.29 
     
Trabecular Dynamic     
Phase Difference (∂) 4.75±1.58 4.95±2.42 4.08±1.67 4.23±1.18 
Storage Modulus (GPa) 13.61±2.47 16.92±2.74a 17.43±2.08a 15.45±2.42a,c 
Loss Modulus (GPa ) 1.07±0.46 1.50±0.74 1.24±0.45 1.17±0.41 
Elasticity (%) 23.10±3.01 22.53±3.22 24.25±5.09 21.62±3.27 
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Figure 1. An illustration of the Regions of Interest (ROI) studied in this work at proximal tibia metaphyseal and mid-tibia. 
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Figure 2. The stress-strain curves for the four genotypes (n=6). 
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Figure 3. A comparison of the mechanical properties of bones obtained from the three-point-bending tests. (a) Maximum load; (b) flexural modulus; (c) 
work-to-fracture; (d) second moment of area (SMA); (e) flexural strength and (f) strain at failure. The boxplots for the four genotypes including the medians, 
the 25 and 75 percentiles and the outliers are also indicated.  
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Figure 4. (A) The fracture morphologies of the genotypes post mechanical testing: 1) WT; 2) mdx; 3) P2RX7-/- and 4) mdx/P2RX7-/-. The initiation 
of cracks path and subsequent fracture are indicated by the arrows. (B) The fracture surfaces of the samples post three-point-bending testing 
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from the SEM analysis, where compression and tension were experienced in anterior (A) and posterior (P), respectively. (C) Details of the 
posterior cortex of the bones showing fibrous fracture surfaces in WT and double mutant bones, as opposed to brittle fracture surfaces in mdx 
bone.   
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Figure 5. The correlation between creep and elasticity of the cortical bones of (a) WT and mdx and (b) mdx and mdx/P2X7-/- from the advanced 
nanoindentation. The results seem to suggest that P2RX7-/- ablation reverses, to a large extent, the effects of the dystrophic abnormality, thus 
the tissue response of mdx/P2X7-/- is close to that of WT bones. 
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